Company Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally.
The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder.
Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood.
The company sells its products through its sales and customer support team to psychiatrists.
Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
| Country | United States |
| IPO Date | Jun 28, 2018 |
| Industry | Medical - Diagnostics & Research |
| Sector | Healthcare |
| Employees | 203 |
| CEO | Keith J. Sullivan |
Contact Details
Address: 3222 Phoenixville Pike Malvern, Pennsylvania United States | |
| Website | https://www.neurostar.com |
Stock Details
| Ticker Symbol | STIM |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001227636 |
| CUSIP Number | 64131A105 |
| ISIN Number | US64131A1051 |
| Employer ID | 00-0000000 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Keith J. Sullivan | President, Chief Executive Officer & Director |
| Lisa Metzner-Rosas | Senior Vice President & Chief Marketing Officer |
| Stephen J. Furlong M.S. | Executive Vice President, Chief Financial Officer & Treasurer |
| Cory S. Anderson | Senior Vice President of R&D and Clinical |
| Rick Grubbs | Senior Vice President of National Accounts |
| Rusty Page | Senior Vice President of Operations & Quality |
| Sara Grubbs | Senior Vice President & Chief Revenue Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 12, 2024 | 4 | Filing |
| Dec 12, 2024 | 4 | Filing |
| Dec 12, 2024 | 4 | Filing |
| Dec 10, 2024 | 8-K | Current Report |
| Nov 14, 2024 | SCHEDULE 13G | Filing |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 14, 2024 | SCHEDULE 13G/A | [Amend] Filing |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 13, 2024 | 8-K/A | [Amend] Current Report |
| Nov 13, 2024 | 8-K | Current Report |